The Registry of Toxic Effects of Chemical Substances
Dibenzo - p - dioxin, 2,3,7,8 - tetrachloro - |
UPDATE: May 2005 | MW: 321.96 | MF: C12H4Cl4O2 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
2 mg
|
moderate
|
EVHPAZ 5,87,1973
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
oral | mouse
100 µg/kg
|
TXAPA9 29,229,1974
|
cytogenetic analysis
|
intraperitoneal | mouse
10 µg/kg
|
PSSID2 5,419,1982
|
cytogenetic analysis
|
oral | rat
100 µg/kg
|
MUREAV 47,141,1978
|
cytogenetic analysis
|
intraperitoneal | rat
10 mg/kg
|
MUREAV 47,141,1978
|
DNA adduct
|
intraperitoneal | rat
40 µg/kg/4 week- intermittent
|
CMSHAF 25,975,1992
|
DNA adduct
|
oral | rat
0.21 mg/kg/30 week- intermittent
|
CRTOEC 14,849,2001
|
DNA damage
|
mouse
other cell types
|
10 nmol/L/24 hour
|
TOLED5 145,55,2003
|
DNA damage
|
oral | rat
100 µg/kg
|
CALEDQ 39,281,1988
|
DNA damage
|
unreported route | rat
100 µg/kg
|
CALEDQ 29,281,1988
|
DNA damage
|
oral | rat
450 ng/kg/30 week- intermittent
|
JJTHEC 65,825,2002
|
DNA inhibition
|
human
other cell types
|
10 nmol/L
|
TXAPA9 77,434,1985
|
DNA inhibition
|
intraperitoneal | mouse
400 µg/kg
|
MUREAV 46,305,1977
|
DNA inhibition
|
intraperitoneal | rat
10 µg/kg
|
CBINA8 8,31,1974
|
DNA inhibition
|
oral | rat
200 µg/kg
|
CBINA8 8,31,1974
|
unscheduled DNA synthesis
|
human
other cell types
|
100 pmol/L
|
CRNGDP 11,1335,1990
|
unscheduled DNA synthesis
|
oral | mouse
800 pmol/kg
|
CRNGDP 8,1433,1987
|
unscheduled DNA synthesis
|
intravenous | rat
4 µg/kg
|
BCPCA6 31,2459,1982
|
unscheduled DNA synthesis
|
oral | rat
5 µg/kg
|
TXCYAC 28,133,1983
|
host-mediated assay
|
mouse
| Saccharomyes cerevisiae
25 µg/kg
|
CMSHAF 12,549,1983
|
mutation in microorganisms
|
Escherichia coli
|
2 mg/L (-enzymatic activation step)
|
AMBOCX 1,1,1972
|
mutation in microorganisms
|
Salmonella typhimurium
|
2 mg/L (+enzymatic activation step)
|
AMBOCX 1,32,1972
|
mutation in microorganisms
|
Saccharomyes cerevisiae
|
10 mg/L (-enzymatic activation step)
|
CMSHAF 12,549,1983
|
mutation in microorganisms
|
Saccharomyes cerevisiae
|
2 mg/L (+enzymatic activation step)
|
PSSID2 5,429,1982
|
gene conversion and mitotic recombination
|
hamster
ovary
|
0.5 nmol/L/24 hour
|
TOXID9 72,369,2003
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
10 mg/L
|
CMSHAF 12,549,1983
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
50 mg/L
|
ENMUDM 4,391,1982
|
morphological transform
|
mouse
fibroblast
|
200 nmol/L
|
ENMUDM 6,461,1984
|
morphological transform
|
mouse
fibroblast
|
10 nmol/L/21 day (-enzymatic activation step)
|
EMMUEG 37,231,2001
|
other mutation test systems
|
mouse
other cell types
|
1 nmol/L
|
JBCHA3 259,12357,1984
|
other mutation test systems
|
oral | mouse
50 µg/kg
|
TXCYAC 56,239,1989
|
phage inhibition capacity
|
Escherichia coli
|
500 µg/L
|
AMBOCX 1,1,1972
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 25 µg/kg (7-11 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
TXCYAC 20,299,1981
|
intraperitoneal | mouse
lowest published toxic dose: 20 µg/kg (11 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
ATSUDG 8,43,1985
|
intraperitoneal | mouse
lowest published toxic dose: 30 µg/kg (14 day pregnant)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material)
|
TOXID9 72(Suppl 1),231,2003
|
intraperitoneal | rat
lowest published toxic dose: 6 µg/kg (17 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
BCPCA6 26,1383,1977
|
intraperitoneal | rat
lowest published toxic dose: 50 µg/kg (1 day after birth)
|
Reproductive: Effects on newborn: Other postnatal measures or effects
|
TXAPA9 173,38,2001
|
oral | hamster
lowest published toxic dose: 18 µg/kg (9 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death
|
CMSHAF 20,1117,1990
|
oral | hamster
lowest published toxic dose: 2 µg/kg (11 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Other postnatal measures or effects
TOSCF2 51,259,1999
|
oral | hamster
lowest published toxic dose: 1 µg/kg (11 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
TXAPA9 131,108,1995
|
oral | hamster
lowest published toxic dose: 2 µg/kg (11 day pregnant)
|
Reproductive: Effects on newborn: Physical
|
TOSCF2 51,259,1999
|
oral | mammal (species unspecified)
lowest published toxic dose: 19 µg/kg (132 day prior to copulation)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
VHTODE 43,134,2001
|
oral | mammal (species unspecified)
lowest published toxic dose: 2.4 µg/kg (132 day prior to copulation)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
VHTODE 43,134,2001
|
oral | mammal (species unspecified)
lowest published toxic dose: 699.6 ng/kg (132 day prior to copulation)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
|
VHTODE 43,134,2001
|
oral | monkey
lowest published toxic dose: 92 ng/kg (46 week prior to copulation-17 week after birth)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Delayed effects
NETEEC 11,13,1989
|
oral | monkey
lowest published toxic dose: 107 mg/kg (4 year male)
|
Reproductive: Effects on newborn: Behavioral
|
CMSHAF 20,1103,1990
|
oral | monkey
lowest published toxic dose: 123 ng/kg (30 week prior to copulation-17 week after birth)
|
Reproductive: Effects on newborn: Behavioral
|
TOXID9 3,68,1983
|
oral | monkey
lowest published toxic dose: 163 ng/kg (182 week prior to copulation)
|
Reproductive: Effects on newborn: Behavioral
|
NETEEC 14,433,1992
|
oral | monkey
lowest published toxic dose: 2 µg/kg (12 day pregnant)
|
Reproductive: Effects on fertility: Abortion
|
BESCE5 13,26,2000
|
oral | monkey
lowest published toxic dose: 0.535 µg/kg (30 week prior to copulation)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on fertility: Abortion
ANYAA9 -,419,1979
|
oral | mouse
lowest published toxic dose: 1 µg/kg (10 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
EVHPAZ 5,81,1973
|
oral | mouse
lowest published toxic dose: 9 µg/kg (12 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TXAPA9 98,487,1989
|
oral | mouse
lowest published toxic dose: 13,500 mg/kg (6-14 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
TJADAB 44,385,1991
|
oral | mouse
lowest published toxic dose: 235 µg/kg (28 day prior to copulation-21 day after birth)
|
Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system
|
DCTODJ 2,77,1979
|
oral | mouse
lowest published toxic dose: 20 µg/kg (14 day pregnant/3 day after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Other postnatal measures or effects
IJIMDS 2,301,1980
|
oral | mouse
lowest published toxic dose: 12 µg/kg (10-13 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetal death
TJADAB 33,29,1986
|
oral | mouse
lowest published toxic dose: 10 µg/kg (14 day pregnant)
|
Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system
|
MOPMA3 35,18,1989
|
oral | mouse
lowest published toxic dose: 12 µg/kg (10-13 day pregnant)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
TOXID9 13,103,1993
|
oral | mouse
lowest published toxic dose: 240 µg/kg (1 day after birth)
|
Reproductive: Effects on newborn: Weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
|
ARTODN 69,87,1994
|
oral | mouse
lowest published toxic dose: 320 µg/kg (1 day after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
ARTODN 69,87,1994
|
oral | mouse
lowest published toxic dose: 480 µg/kg (1 day after birth)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
ARTODN 69,87,1994
|
oral | mouse
lowest published toxic dose: 3 µg/kg (8 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Physical
TOSCF2 52,45,1999
|
oral | mouse
lowest published toxic dose: 15 µg/kg (14 day pregnant)
|
Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system | Reproductive: Specific developmental abnormalities: Blood and lymphatic systems (including spleen and marrow)
CMSHAF 25,103,1992
|
oral | mouse
lowest published toxic dose: 50 µg/kg (105 day prior to copulation)
|
Reproductive: Maternal effects: Uterus, cervix, vagina | Reproductive: Maternal effects: Ovaries, fallopian tubes Reproductive: Other reproductive system tumors
EVHPAZ 105,750,1997
|
oral | mouse
lowest published toxic dose: 5 µg/kg (9 day pregnant)
|
Reproductive: Other effects to embryo or fetus | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
ARTODN 67,591,1993
|
oral | mouse
lowest published toxic dose: 40 µg/kg (12 day pregnant)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material)
|
TCMUD8 20,73,2000
|
oral | mouse
lowest published toxic dose: 5 µg/kg (12 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system
|
TOXID9 72(Suppl 1),365,2003
|
oral | mouse
lowest published toxic dose: 10 µg/kg (13 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOXID9 72(Suppl 1),366,2003
|
oral | mouse
lowest published toxic dose: 10 µg/kg (17 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOXID9 72(Suppl 1),366,2003
|
oral | mouse
lowest published toxic dose: 6 µg/kg (14 day pregnant)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
TOXID9 72(Suppl 1),231,2003
|
oral | mouse
lowest published toxic dose: 0.2 µg/kg (12 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Urogenital system
TOSCF2 71,84,2003
|
oral | mouse
lowest published toxic dose: 5 µg/kg (13 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Skin and skin appendages
TOSCF2 68,465,2002
|
oral | mouse
lowest published toxic dose: 5 µg/kg (13 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system | Reproductive: Effects on newborn: Other postnatal measures or effects
TOSCF2 68,479,2002
|
oral | mouse
lowest published toxic dose: 5 µg/kg (13 day pregnant)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material) | Reproductive: Specific developmental abnormalities: Urogenital system
TOSCF2 76,171,2003
|
oral | mouse
lowest published toxic dose: 5 µg/kg (12 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) Reproductive: Specific developmental abnormalities: Urogenital system
TOSCF2 71,84,2003
|
oral | rat
lowest published toxic dose: 1,500 ng/kg (1-3 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Urogenital system
TJADAB 25(1),21A,1982
|
oral | rat
lowest published toxic dose: 1,250 ng/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Other developmental abnormalities
FCTXAV 9,405,1971
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death | Reproductive: Specific developmental abnormalities: Urogenital system Reproductive: Effects on newborn: Other neonatal measures or effects
TXAPA9 150,254,1998
|
oral | rat
lowest published toxic dose: 1,270 ng/kg (multigenerations)
|
Reproductive: Effects on fertility: Other measures of fertility | Reproductive: Specific developmental abnormalities: Blood and lymphatic systems (including spleen and marrow) Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TXAPA9 50,241,1979
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day after birth)
|
Reproductive: Effects on newborn: Physical
|
TXAPA9 140,146,1996
|
oral | rat
lowest published toxic dose: 20 µg/kg (1 day prior to copulation)
|
Reproductive: Maternal effects: Uterus, cervix, vagina
|
TXCYAC 21,77,1981
|
oral | rat
lowest published toxic dose: 12 µg/kg (10 day pregnant)
|
Reproductive: Effects on embryo or fetus: Cytological changes (including somatic cell genetic material) | Reproductive: Specific developmental abnormalities: Urogenital system
TJADAB 55,326,1997
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOXID9 13,104,1993
|
oral | rat
lowest published toxic dose: 1 µg/kg (8 day pregnant)
|
Reproductive: Effects on fertility: Other measures of fertility | Reproductive: Specific developmental abnormalities: Endocrine system Reproductive: Specific developmental abnormalities: Urogenital system
TXAPA9 133,285,1995
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system | Reproductive: Specific developmental abnormalities: Urogenital system Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TXAPA9 133,285,1995
|
oral | rat
lowest published toxic dose: 0.5 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
TXAPA9 146,11,1997
|
oral | rat
lowest published toxic dose: 56 mg/kg (10-16 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system | Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system
TOLED5 78,253,1995
|
oral | rat
lowest published toxic dose: 0.7 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Behavioral
TOXID9 14,197,1994
|
oral | rat
lowest published toxic dose: 0.64 µg/kg (15 day pregnant)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct Reproductive: Specific developmental abnormalities: Urogenital system
TOXID9 10,313,1990
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Specific developmental abnormalities: Urogenital system Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
TXAPA9 127,241,1994
|
oral | rat
lowest published toxic dose: 0.7 µg/kg (15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Effects on embryo or fetus: Fetal death Reproductive: Specific developmental abnormalities: Urogenital system
TXAPA9 127,250,1994
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system | Reproductive: Specific developmental abnormalities: Urogenital system
BIREBV 55,62,1996
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Specific developmental abnormalities: Urogenital system
TXAPA9 140,146,1996
|
oral | rat
lowest published toxic dose: 1 µg/kg (11 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
TOXID9 15,292,1995
|
oral | rat
lowest published toxic dose: 1 µg/kg (18 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
TOXID9 15,292,1995
|
oral | rat
lowest published toxic dose: 1 µg/kg (8 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Physical
TOSCF2 52,45,1999
|
oral | rat
lowest published toxic dose: 800 ng/kg (15 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Other effects to embryo or fetus Reproductive: Effects on newborn: Biochemical and metabolic
ETOPFR 11,1,2002
|
oral | rat
lowest published toxic dose: 0.3 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TXAPA9 174,216,2001
|
oral | rat
lowest published toxic dose: 1.4 µg/kg (10-15 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Other postnatal measures or effects
NETEEC 22,511,2001
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system | Reproductive: Specific developmental abnormalities: Urogenital system Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
TXAPA9 134,241,1995
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Effects on newborn: Delayed effects
TXAPA9 134,241,1995
|
oral | rat
lowest published toxic dose: 0.35 µg/kg (16 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
CMSHAF 18,955,1989
|
oral | rat
lowest published toxic dose: 0.125 µg/kg (16 day pregnant)
|
Reproductive: Specific developmental abnormalities: Hepatobiliary system
|
CMSHAF 18,955,1989
|
oral | rat
lowest published toxic dose: 13 µg/kg (7-19 day pregnant)
|
Reproductive: Specific developmental abnormalities: Gastrointestinal system | Reproductive: Other developmental abnormalities
BCPCA6 32,991,1983
|
oral | rat
lowest published toxic dose: 12 µg/kg (4-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Gastrointestinal system
|
BCPCA6 32,991,1983
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) Reproductive: Effects on newborn: Physical
BIRSB5 62,184,2000
|
oral | rat
lowest published toxic dose: 0.18 µg/kg (15 day pregnant)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Delayed effects
NETEEC 24,209,2002
|
oral | rat
lowest published toxic dose: 45 ng/kg (45 day male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Paternal effects: Testes, epididymis, sperm duct Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands
JJATDK 22,345,2002
|
oral | rat
lowest published toxic dose: 700 ng/kg (14 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Other developmental abnormalities
TOXID9 72,125,2003
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Other neonatal measures or effects Reproductive: Effects on newborn: Biochemical and metabolic
EVHPAZ 110(Suppl 3),369,2002
|
oral | rat
lowest published toxic dose: 20 ng/kg (8 day pregnant)
|
Endocrine: Differential effect of sex or castration on observed toxicity | Reproductive: Effects on newborn: Behavioral
EVHPAZ 110,247,2002
|
oral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | Reproductive: Specific developmental abnormalities: Endocrine system
BIREBV 66,1621,2002
|
oral | rat
lowest published toxic dose: 20 ng/kg (18 day pregnant)
|
Reproductive: Effects on newborn: Behavioral
|
EVHPAZ 109,621,2001
|
oral | rat
lowest published toxic dose: 1 µg/kg (11 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system | Reproductive: Effects on newborn: Stillbirth
TXAPA9 184,57,2002
|
oral | rat
lowest published toxic dose: 800 ng/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) Reproductive: Effects on newborn: Behavioral
NRTXDN 24,207,2003
|
oral | rat
lowest published toxic dose: 1,000 ng/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
TOXID9 72(Suppl 1),232,2003
|
oral | rat
lowest published toxic dose: 0.7 µg/kg (10-16 day pregnant)
|
Reproductive: Effects on newborn: Behavioral | Reproductive: Effects on newborn: Delayed effects
NETEEC 25,459,2003
|
oral | rabbit
lowest published toxic dose: 2,500 ng/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Specific developmental abnormalities: Urogenital system
ENVRAL 27,74,1982
|
oral | rabbit
lowest published toxic dose: 10 µg/kg (6-15 day pregnant)
|
Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) | Reproductive: Effects on fertility: Abortion
ENVRAL 27,74,1982
|
oral | rabbit
lowest published toxic dose: 1 µg/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
ENVRAL 27,74,1982
|
parenteral | rat
lowest published toxic dose: 1 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
TOXID9 14,197,1994
|
subcutaneous | mouse
lowest published toxic dose: 250 µg/kg (7-16 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) | Reproductive: Specific developmental abnormalities: Musculoskeletal system Reproductive: Specific developmental abnormalities: Urogenital system
BECTA6 16,674,1976
|
subcutaneous | mouse
lowest published toxic dose: 250 µg/kg (7-16 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on embryo or fetus: Fetal death
BECTA6 16,674,1976
|
subcutaneous | mouse
lowest published toxic dose: 100 µg/kg (2 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
TCMUD8 4,427,1984
|
subcutaneous | mouse
lowest published toxic dose: 30 µg/kg (10 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
MOPMA3 17,86,1980
|
subcutaneous | mouse
lowest published toxic dose: 100 µg/kg (10 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TCMUD8 4,427,1984
|
subcutaneous | mouse
lowest published toxic dose: 90 µg/kg (8 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TJADAB 21,62A,1980
|
subcutaneous | mouse
lowest published toxic dose: 90 µg/kg (9 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TJADAB 21,62A,1980
|
subcutaneous | mouse
lowest published toxic dose: 90 µg/kg (11 day pregnant)
|
Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
|
TJADAB 21,62A,1980
|
subcutaneous | rat
lowest published toxic dose: 5 mg/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
TXAPA9 20,396,1971
|
subcutaneous | rat
lowest published toxic dose: 2,200 ng/kg (19 day pregnant/21 day after birth)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
CMSHAF 25,1227,1992
|
subcutaneous | rat
lowest published toxic dose: 0.5 µg/kg (7-20 day pregnant/9-16 day after birth)
|
Reproductive: Specific developmental abnormalities: Respiratory system | Reproductive: Effects on newborn: Biochemical and metabolic
BCPCA6 62,617,2001
|
subcutaneous | rat
lowest published toxic dose: 185 ng/kg (2 week prior to copulation-3 week after birth)
|
Reproductive: Effects on newborn: Germ cell effects (in offspring)
|
TXAPA9 150,383,1998
|
subcutaneous | rat
lowest published toxic dose: 2,700 ng/kg (2 week prior to copulation-3 week after birth)
|
Reproductive: Specific developmental abnormalities: Endocrine system
|
TXAPA9 150,383,1998
|
subcutaneous | rat
lowest published toxic dose: 3 µg/kg (19 day pregnant)
|
Reproductive: Effects on newborn: Biochemical and metabolic
|
TJADAB 40,292,1989
|
subcutaneous | rat
lowest published toxic dose: 0.5 µg/kg (7-20 day pregnant/2 day after birth)
|
Reproductive: Specific developmental abnormalities: Hepatobiliary system
|
BCPCA6 59,1147,2000
|
unreported route | mouse
lowest published toxic dose: 12 µg/kg (6-14 day pregnant)
|
Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system
|
CMSHAF 25,115,1992
|
unreported route | mouse
lowest published toxic dose: 5 µg/kg (13 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOXID9 72,113,2003
|
unreported route | mouse
lowest published toxic dose: 1.5 µg/kg (0-14 day pregnant)
|
Reproductive: Specific developmental abnormalities: Immune and reticuloendothelial system
|
TOXID9 72,121,2003
|
unreported route | mouse
lowest published toxic dose: 5.5 µg/kg (0-14 day pregnant)
|
Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive)
|
TOXID9 72,121,2003
|
unreported route | rat
lowest published toxic dose: 1,500 mg/kg (1 day male)
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct | Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands
ATSUDG 11,344,1987
|
unreported route | rat
lowest published toxic dose: 0.7 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
TOXID9 14,382,1994
|
unreported route | rat
lowest published toxic dose: 0.8 µg/kg (15 day pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
HBPTO* 1,741,2001
|
unreported route | rat
lowest published toxic dose: 0.2 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Urogenital system
|
HBPTO* 1,741,2001
|
unreported route | rat
lowest published toxic dose: 0.5 µg/kg (15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Endocrine system | Reproductive: Effects on newborn: Physical
HBPTO* 1,741,2001
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 1.61 µg/kg
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Tumorigenic: Facilitates action of known carcinogens
TXAPA9 179,21,2002
|
oral | mouse
lowest published toxic dose: 52 µg/kg/2 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Endocrine: Thyroid tumors
NTPTR* NTP-TR-209,1982
|
oral | mouse
toxic dose : 1 µg/kg/2 year- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors Endocrine: Thyroid tumors
NTPTR* NTP-TR-209,1982
|
oral | mouse
toxic dose : 36 µg/kg/52 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Liver: Tumors
NATUAS 278,548,1979
|
oral | mouse
lowest published toxic dose: 0.52 mg/kg/104 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
NTIS** PB82-163445
|
oral | mouse
lowest published toxic dose: 0.208 mg/kg/104 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Endocrine: Thyroid tumors
NTIS** PB82-163445
|
oral | rat
lowest published toxic dose: 52 µg/kg/2 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors Endocrine: Thyroid tumors
NTPTR* NTP-TR-209,1982
|
oral | rat
toxic dose : 328 µg/kg/78 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Tumors
PESTC* 5,12,1977
|
oral | rat
toxic dose : 137 µg/kg/65 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors Kidney, Ureter, and Bladder: Kidney tumors
FEPRA7 36,396,1977
|
oral | rat
toxic dose : 73 µg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
ANYAA9 320,397,1979
|
oral | rat
toxic dose : 1 µg/kg/2 year- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors Endocrine: Thyroid tumors
NTPTR* NTP-TR-209,1982
|
oral | rat
lowest published toxic dose: 164 µg/kg/78 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Lung, Thorax, or Respiration: Tumors Liver: Tumors
CMSHAF 6,625,1977
|
oral | rat
toxic dose : 190 µg/kg/95 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Lung, Thorax, or Respiration: Tumors Liver: Tumors
CMSHAF 6,537,1977
|
oral | rat
toxic dose : 27 µg/kg/65 week- continuous
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Liver: Tumors Kidney, Ureter, and Bladder: Kidney tumors
FEPRA7 36,396,1977
|
oral | rat
lowest published toxic dose: 0.52 mg/kg/104 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Endocrine: Thyroid tumors
NTIS** PB82-163445
|
oral | rat
lowest published toxic dose: 0.52 mg/kg/104 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Liver: Tumors
NTIS** PB82-163445
|
skin | mouse
lowest published toxic dose: 62 µg/kg/2 year- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Skin and Appendages: Tumors
NCITR* NCI-TR-201,1982
|
skin | mouse
toxic dose : 80 µg/kg
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Skin and Appendages: Tumors Tumorigenic: Tumors at site of application
BECTA6 18,552,1977
|
skin | mouse
lowest published toxic dose: 0.594 mg/kg/99 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Skin and Appendages: Tumors
NTIS** PB82-163684
|
skin | mouse
lowest published toxic dose: 0.1,188 mg/kg/99 week- intermittent
|
Tumorigenic: Equivocal tumorigenic agent by RTECS criteria | Skin and Appendages: Tumors
NTIS** PB82-163684
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | wild bird
lowest published toxic dose: 20 µg/kg
|
Endocrine: Evidence of thyroid hyperfunction | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
ETOCDK 16,985,1997
|
intraperitoneal | chicken
lowest published lethal dose: 25 µg/kg
|
Behavioral: Food intake (animal) | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Nutritional and Gross Metabolic: Other changes
JTEHD6 35,187,1992
|
intraperitoneal | guinea pig
lowest published toxic dose: 29.9 ng/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
BCPCA6 36,1535,1988
|
intraperitoneal | guinea pig
lowest published toxic dose: 1.8 µg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
BCPCA6 36,1535,1988
|
intraperitoneal | hamster
lethal dose (50 percent kill): >3 mg/kg
|
Endocrine: Changes in thymus weight | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 55,67,1980
|
intraperitoneal | hamster
lowest published toxic dose: 1 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
BCPCA6 35,2737,1986
|
intraperitoneal | hamster
lowest published toxic dose: 10 µg/kg
|
Liver: Changes in liver weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
BCPCA6 35,2737,1986
|
intraperitoneal | hamster
lowest published toxic dose: 100 µg/kg
|
Endocrine: Changes in thymus weight
|
BCPCA6 35,2737,1986
|
intraperitoneal | hamster
lowest published toxic dose: 500 µg/kg
|
Liver: Other changes
|
BCPCA6 35,2737,1986
|
intraperitoneal | mouse
lethal dose (50 percent kill): 120 µg/kg
|
N/R
|
SCAMAC 254,29,1986
|
intraperitoneal | mouse
lowest published toxic dose: 0.6 µg/kg
|
Immunological Including Allergic: Decrease in humoral immune response
|
TXCYAC 92,155,1994
|
intraperitoneal | mouse
lowest published toxic dose: 10 µg/kg
|
Blood: Luekopenia | Blood: Changes in bone marrow not included in above
CMSHAF 43,819,2001
|
intraperitoneal | mouse
lowest published toxic dose: 9.66 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
MOPMA3 13,924,1977
|
intraperitoneal | mouse
lowest published toxic dose: 782 ng/kg
|
Immunological Including Allergic: Decrease in humoral immune response | Immunological Including Allergic: Decreased immune response
TXAPA9 94,141,1988
|
intraperitoneal | mouse
lowest published toxic dose: 1.5 µg/kg
|
Blood: Changes in spleen | Immunological Including Allergic: Decrease in cellular immune response Immunological Including Allergic: Decreased immune response
TXCYAC 80,217,1993
|
intraperitoneal | mouse
lowest published toxic dose: 0.29 µg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
TXCYAC 80,217,1993
|
intraperitoneal | mouse
lowest published toxic dose: 20 µg/kg
|
Blood: Changes in bone marrow not included in above | Biochemical: Metabolism (intermediary): Effect on cyclic nucleotides
AECTCV 41,232,2001
|
intraperitoneal | mouse
lowest published toxic dose: 50 µg/kg
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
TOXID9 72,66,2003
|
intraperitoneal | mouse
lowest published toxic dose: 0.1 µg/kg
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
TOXID9 72,66,2003
|
intraperitoneal | mouse
lowest published toxic dose: 30 µg/kg
|
Endocrine: Other changes | Blood: Changes in bone marrow not included in above Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
CMSHAF 25,103,1992
|
intraperitoneal | mouse
lowest published toxic dose: 11.19 µg/kg
|
Immunological Including Allergic: Decrease in cellular immune response | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TXCYAC 63,97,1990
|
intraperitoneal | mouse
lowest published toxic dose: 0.5 mg/kg
|
Endocrine: Changes in thymus weight
|
BBRCA9 178,16,1991
|
intraperitoneal | mouse
lowest published toxic dose: 30 µg/kg
|
Endocrine: Changes in thymus weight | Blood: Changes in bone marrow not included in above
TOSCF2 69,117,2002
|
intraperitoneal | mouse
lowest published toxic dose: 15 µg/kg
|
Blood: Methemoglobinemia- Carboxhemoglobinemia
|
TXAPA9 181,32,2002
|
intraperitoneal | mouse
lowest published toxic dose: 115 µg/kg
|
Liver: Changes in liver weight | Endocrine: Changes in thymus weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 172,125,2002
|
intraperitoneal | mouse
lowest published toxic dose: 0.1 µg/kg
|
Blood: Changes in spleen | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXCYAC 178,241,2002
|
intraperitoneal | mouse
lowest published toxic dose: 5 µg/kg
|
Liver: Fatty liver degeneration
|
TOXID9 72(Suppl 1),336,2003
|
intraperitoneal | mouse
lowest published toxic dose: 10 µg/kg
|
Immunological Including Allergic: Decrease in cellular immune response
|
TOXID9 72(Suppl 1),231,2003
|
intraperitoneal | mouse
lowest published toxic dose: 5 µg/kg
|
Reproductive: Maternal effects: Uterus, cervix, vagina | Biochemical: Metabolism (intermediary): Effect on cyclic nucleotides Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TOSCF2 66,62,2002
|
intraperitoneal | mouse
lowest published toxic dose: 0.1 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
|
TOSCF2 69,109,2002
|
intraperitoneal | mouse
lowest published toxic dose: 1 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | Biochemical: Metabolism (intermediary): Lipids including transport
TOSCF2 69,109,2002
|
intraperitoneal | mouse
lowest published toxic dose: 10 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | Biochemical: Metabolism (intermediary): Lipids including transport Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TOSCF2 69,109,2002
|
intraperitoneal | mouse
lowest published toxic dose: 30 µg/kg
|
Endocrine: Changes in thymus weight | Blood: Changes in bone marrow not included in above Immunological Including Allergic: Decreased immune response
TOLED5 129,1,2002
|
intraperitoneal | rat
lethal dose (50 percent kill): 24,600 ng/kg
|
N/R
|
TXAPA9 45,513,1978
|
intraperitoneal | rat
lowest published toxic dose: 1 µg/kg
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
|
TXAPA9 150,427,1998
|
intraperitoneal | rat
lowest published toxic dose: 10 µg/kg
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXAPA9 150,427,1998
|
intraperitoneal | rat
lowest published toxic dose: 12.5 µg/kg
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct | Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 89,49,1994
|
intraperitoneal | rat
lowest published toxic dose: 82.4 µg/kg
|
Endocrine: Estrogenic | Endocrine: Other changes
CMSHAF 19,785,1989
|
intraperitoneal | rat
lowest published toxic dose: 100 µg/kg
|
Endocrine: Other changes | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JTEHD6 16,481,1985
|
intraperitoneal | rat
lowest published toxic dose: 9.66 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
MOPMA3 13,924,1977
|
intraperitoneal | rat
lowest published toxic dose: 1 µg/kg
|
Endocrine: Evidence of thyroid hypofunction | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 44,297,1987
|
intraperitoneal | rat
lowest published lethal dose: 25 µg/kg
|
Endocrine: Other changes
|
TXCYAC 44,297,1987
|
intraperitoneal | rat
lowest published toxic dose: 125 µg/kg
|
Behavioral: Food intake (animal) | Endocrine: Hypoglycemia
TXCYAC 44,297,1987
|
intraperitoneal | rat
lowest published toxic dose: 10.3 µg/kg
|
Liver: Other changes | Endocrine: Estrogenic
TXAPA9 95,435,1988
|
intraperitoneal | rat
lowest published toxic dose: 20 µg/kg
|
Endocrine: Estrogenic
|
TXAPA9 92,368,1988
|
intraperitoneal | rat
lowest published toxic dose: 10 µg/kg
|
Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TXCYAC 29,61,1983
|
intraperitoneal | rat
lowest published toxic dose: 5 µg/kg
|
Endocrine: Changes in spleen weight | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
ATXKA8 53,177,1983
|
intraperitoneal | rat
lowest published toxic dose: 5 µg/kg
|
Liver: Other changes | Blood: Changes in spleen Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
ARTODN 53,177,1983
|
intraperitoneal | rat
lowest published toxic dose: 5 µg/kg
|
Endocrine: Other changes | Blood: Changes in spleen Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
ARTODN 53,177,1983
|
intraperitoneal | rat
lowest published toxic dose: 125 µg/kg
|
Behavioral: Food intake (animal) | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport
ARTODN 62,146,1988
|
intraperitoneal | rat
lowest published toxic dose: 10 µg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport
LPDSAP 23,904,1988
|
intraperitoneal | rat
lowest published toxic dose: 1 µg/kg
|
Liver: Changes in liver weight | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport
LPDSAP 23,904,1988
|
intraperitoneal | rat
lowest published toxic dose: 10 µg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Lipids including transport
JPETAB 248,62,1989
|
intraperitoneal | rat
lowest published toxic dose: 5 µg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
ARTODN 53,177,1983
|
intraperitoneal | rat
lethal dose (50 percent kill): 60 µg/kg
|
Endocrine: Changes in thymus weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other hydrolases
BBRCA9 125,996,1984
|
intraperitoneal | rat
lowest published toxic dose: 2.5 µg/kg
|
Endocrine: Changes in thymus weight
|
BBRCA9 160,1003,1989
|
intraperitoneal | rat
lowest published toxic dose: 25 µg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
BBRCA9 160,1003,1989
|
intraperitoneal | rat
lowest published toxic dose: 50 µg/kg
|
Endocrine: Change in gonadotropins | Biochemical: Neurotransmitters or modulators (putative): Dopamine at other sites
TXAPA9 94,496,1988
|
intraperitoneal | rat
lowest published toxic dose: 12.5 µg/kg
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct
|
TXCYAC 76,103,1992
|
intraperitoneal | rat
lowest published toxic dose: 25 µg/kg
|
Endocrine: Androgenic | Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 76,103,1992
|
intraperitoneal | rat
lowest published toxic dose: 50 µg/kg
|
Related to Chronic Data: Changes in testicular weight
|
TXCYAC 76,103,1992
|
intraperitoneal | rat
lowest published toxic dose: 25 µg/kg
|
Behavioral: Food intake (animal) | Endocrine: Adrenal cortex hyperplasia Endocrine: Changes in thymus weight
TXCYAC 53,19,1988
|
intraperitoneal | rat
lowest published lethal dose: 125 µg/kg
|
N/R
|
TXCYAC 53,19,1988
|
intraperitoneal | rat
lowest published toxic dose: 19.31 µg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Metabolism (intermediary): Other
CJPPA3 63,1537,1985
|
intraperitoneal | rat
lowest published toxic dose: 20 µg/kg
|
Reproductive: Maternal effects: Uterus, cervix, vagina | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
BCPCA6 39,485,1990
|
intraperitoneal | rat
lowest published toxic dose: 80 µg/kg
|
Related to Chronic Data: Changes in uterine weight
|
BCPCA6 39,485,1990
|
intraperitoneal | rat
lowest published toxic dose: 100 µg/kg
|
Endocrine: Evidence of thyroid hypofunction | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TXCYAC 37,51,1985
|
intraperitoneal | rabbit
lethal dose (50 percent kill): 252 µg/kg
|
N/R
|
SCAMAC 254,29,1986
|
oral | chicken
lowest published lethal dose: 25 µg/kg
|
Lung, Thorax, or Respiration: Dyspnea | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FCTXAV 11,585,1973
|
oral | dog
lethal dose (50 percent kill): 1 µg/kg
|
N/R
|
EXPEAM 38,879,1982
|
oral | frog
lethal dose (50 percent kill): 1 mg/kg
|
N/R
|
SCAMAC 254,29,1986
|
oral | guinea pig
lethal dose (50 percent kill): 500 ng/kg
|
N/R
|
EVSRBT 2,708,1973
|
oral | hamster
lethal dose (50 percent kill): 1,157 µg/kg
|
Gastrointestinal: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 55,67,1980
|
oral | hamster
lethal dose (50 percent kill): 5,051 µg/kg
|
N/R
|
TAEHC* VI:88 ,1,1989
|
oral | mammal (species unspecified)
lethal dose (50 percent kill): 4,200 ng/kg
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Blood: Changes in spleen
AECTCV 17,33,1988
|
oral | monkey
lethal dose (50 percent kill): 2 µg/kg
|
N/R
|
EXPEAM 38,879,1982
|
oral | monkey
lowest published toxic dose: 0.4 mg/kg
|
Reproductive: Maternal effects: Ovaries, fallopian tubes | Reproductive: Maternal effects: Menstrual cycle changes or disorders
REPTED 15,377,2001
|
oral | mouse
lethal dose (50 percent kill): 114 µg/kg
|
Eye: Mydriasis (pupilliary dilation) | Behavioral: Convulsions or effect on seizure threshold Cardiac: Other changes
TXAPA9 29,229,1974
|
oral | mouse
lowest published toxic dose: 10 µg/kg
|
Behavioral: Change in motor activity (specific assay)
|
TOSCF2 56,114,2000
|
oral | mouse
lowest published toxic dose: 50 µg/kg
|
Endocrine: Other changes | Biochemical: Metabolism (intermediary): Other proteins Biochemical: Metabolism (intermediary): Other
NRTXDN 23,783,2002
|
oral | mouse
lowest published toxic dose: 400 µg/kg
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXAPA9 190,120,2003
|
oral | mouse
lowest published toxic dose: 4,000 µg/kg
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXAPA9 190,120,2003
|
oral | mouse
lowest published toxic dose: 50 µg/kg
|
Liver: Changes in liver weight | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Metabolism (intermediary): Other proteins
TXAPA9 192,262,2003
|
oral | mouse
lowest published toxic dose: 10 µg/kg
|
Lung, Thorax, or Respiration: Other changes | Immunological Including Allergic: Decrease in humoral immune response Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TXAPA9 192,275,2003
|
oral | mouse
lowest published toxic dose: 0.3 µg/kg
|
Immunological Including Allergic: Decrease in cellular immune response
|
TOXID9 72(Suppl 1),403,2003
|
oral | mouse
lowest published toxic dose: 0.3 µg/kg
|
Liver: Changes in liver weight
|
TOXID9 72(Suppl 1),403,2003
|
oral | mouse
lowest published toxic dose: 5 µg/kg
|
Immunological Including Allergic: Decrease in humoral immune response | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXCYAC 172,49,2002
|
oral | mouse
lowest published toxic dose: 20 µg/kg
|
Endocrine: Changes in thymus weight | Immunological Including Allergic: Decrease in humoral immune response Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXCYAC 172,49,2002
|
oral | mouse
lowest published toxic dose: 156 µg/kg
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes in urine composition
TOXID9 72(Suppl 1),363,2003
|
oral | mouse
lowest published toxic dose: 0.1 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
TOXID9 72(Suppl 1),364,2003
|
oral | mouse
lowest published toxic dose: 5 µg/kg
|
Liver: Other changes | Blood: Other changes
TOXID9 72(Suppl 1),364,2003
|
oral | mouse
lowest published toxic dose: 12.5 µg/kg
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Biochemical: Metabolism (intermediary): Lipids including transport
TXCYAC 175,73,2002
|
oral | mouse
lowest published toxic dose: 5 µg/kg
|
Immunological Including Allergic: Decrease in cellular immune response | Immunological Including Allergic: Decrease in humoral immune response Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXCYAC 188,15,2003
|
oral | mouse
lowest published toxic dose: 20 µg/kg
|
Endocrine: Changes in spleen weight | Endocrine: Changes in thymus weight Immunological Including Allergic: Decrease in humoral immune response
TOSCF2 66,117,2002
|
oral | rat
lethal dose (50 percent kill): 20 µg/kg
|
N/R
|
EXPEAM 38,879,1982
|
oral | rat
lowest published toxic dose: 50 µg/kg
|
Endocrine: Adrenal cortex hypoplasia | Endocrine: Other changes
NETEEC 15,365,1993
|
oral | rat
lowest published toxic dose: 90 µg/kg
|
Endocrine: Changes in spleen weight
|
TXCYAC 106,221,1996
|
oral | rat
lowest published toxic dose: 10 µg/kg
|
Immunological Including Allergic: Increase in humoral response | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 106,221,1996
|
oral | rat
lowest published toxic dose: 1 µg/kg
|
Endocrine: Changes in thymus weight | Immunological Including Allergic: Decreased immune response Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXCYAC 106,221,1996
|
oral | rat
lowest published toxic dose: 5 µg/kg
|
Endocrine: Changes in thymus weight
|
TXAPA9 128,97,1994
|
oral | rat
lowest published toxic dose: 0.3 µg/kg
|
Endocrine: Change in LH | Endocrine: Change in gonadotropins
TXAPA9 142,264,1997
|
oral | rat
lowest published toxic dose: 1 µg/kg
|
Liver: Other changes | Nutritional and Gross Metabolic: Changes in: Other metals Biochemical: Metabolism (intermediary): Other proteins
LIFSAK 69,1291,2001
|
oral | rat
lowest published toxic dose: 2 µg/kg
|
Nutritional and Gross Metabolic: Changes in: Fe
|
LIFSAK 69,1291,2001
|
oral | rat
lowest published toxic dose: 4 µg/kg
|
Nutritional and Gross Metabolic: Changes in: Other metals
|
LIFSAK 69,1291,2001
|
oral | rat
lowest published toxic dose: 1 µg/kg
|
Vascular: BP elevation not characterized in autonomic section | Cardiac: Pulse rate decreased with fall in BP Nutritional and Gross Metabolic: Body temperature decrease
TXCYAC 145,227,2000
|
oral | rat
lowest published toxic dose: 0.2 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
EVHPAZ 5,199,1973
|
oral | rat
lowest published toxic dose: 1 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
|
EVHPAZ 5,199,1973
|
oral | rat
lowest published toxic dose: 50 µg/kg
|
Endocrine: Change in LH | Endocrine: Androgenic Reproductive: Paternal effects: Testes, epididymis, sperm duct
BIREBV 45,143,1991
|
oral | rat
lowest published toxic dose: 100 µg/kg
|
Endocrine: Androgenic
|
TXAPA9 105,78,1990
|
oral | rat
lowest published toxic dose: 6.25 µg/kg
|
Behavioral: Food intake (animal) | Lung, Thorax, or Respiration: Respiratory depression Endocrine: Other changes
TXAPA9 84,45,1986
|
oral | rat
lowest published toxic dose: 12.5 µg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
TXAPA9 84,45,1986
|
oral | rat
lowest published toxic dose: 25 µg/kg
|
Endocrine: Other changes
|
BCPCA6 33,2531,1984
|
oral | rat
lowest published toxic dose: 10 µg/kg
|
Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
JPETAB 215,601,1980
|
oral | rat
lowest published toxic dose: 12.5 mg/kg
|
Endocrine: Androgenic | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) Biochemical: Metabolism (intermediary): Other
BCPCA6 36,727,1987
|
oral | rat
lowest published toxic dose: 25 µg/kg
|
Reproductive: Paternal effects: Testes, epididymis, sperm duct | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
BCPCA6 31,3663,1982
|
oral | rat
lowest published toxic dose: 50 µg/kg
|
Endocrine: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) Biochemical: Metabolism (intermediary): Other
BCPCA6 35,4359,1986
|
oral | rat
lowest published toxic dose: 100 µg/kg
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands
TXAPA9 106,112,1990
|
oral | rat
lowest published toxic dose: 0.1 mg/kg
|
Reproductive: Maternal effects: Oogenesis | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Changes in ovarian weight
TXAPA9 133,321,1995
|
oral | rat
lowest published toxic dose: 10 µg/kg
|
Reproductive: Maternal effects: Oogenesis | Reproductive: Maternal effects: Menstrual cycle changes or disorders Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TOLED5 78,219,1995
|
oral | rat
lowest published toxic dose: 50 µg/kg
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation)
CRTOEC 13,1051,2000
|
oral | rat
lowest published toxic dose: 2.5 µg/kg
|
Skin and Appendages: Other: Breast | Skin and Appendages: Tumors Tumorigenic: Facilitates action of known carcinogens
EVHPAZ 109,739,2001
|
oral | rat
lowest published toxic dose: 0.14 µg/kg
|
Liver: Other changes
|
TXAPA9 187,128,2003
|
oral | rat
lowest published toxic dose: 0.83 µg/kg
|
Liver: Other changes | Endocrine: Changes in thymus weight
TXAPA9 187,128,2003
|
oral | rat
lowest published toxic dose: 5.5 µg/kg
|
Liver: Other changes | Endocrine: Changes in thymus weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 187,128,2003
|
oral | rat
lowest published toxic dose: 0.77 µg/kg
|
Endocrine: Evidence of thyroid hypofunction
|
TXAPA9 181,38,2002
|
oral | rat
lowest published toxic dose: 2.3 µg/kg
|
Endocrine: Evidence of thyroid hypofunction | Endocrine: Changes in thymus weight
TXAPA9 181,38,2002
|
oral | rat
lowest published toxic dose: 6.3 µg/kg
|
Endocrine: Evidence of thyroid hypofunction | Endocrine: Changes in thymus weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 181,38,2002
|
oral | rat
lowest published toxic dose: 1 µg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TXCYAC 171,73,2002
|
oral | rat
lowest published toxic dose: 4 µg/kg
|
Liver: Other changes | Endocrine: Evidence of thyroid hypofunction Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TXCYAC 171,73,2002
|
oral | rat
lowest published toxic dose: 50 µg/kg
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
TOXID9 72(Suppl 1),361,2003
|
oral | rat
lowest published toxic dose: 300 µg/kg
|
Liver: Hepatitis (hepatocellular necrosis), zonal | Liver: Other changes
TOSCF2 71,112,2003
|
oral | rat
lowest published toxic dose: 10 µg/kg
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
CBINA8 145,1,2003
|
oral | rat
lowest published toxic dose: 1 µg/kg
|
Kidney, Ureter, and Bladder: Other changes
|
CBINA8 145,1,2003
|
oral | rat
lowest published toxic dose: 0.1 µg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Cytochrome oxidases (indlucing oxidative phosphrylation) Biochemical: Metabolism (intermediary): Other
CBINA8 145,1,2003
|
oral | rabbit
lethal dose (50 percent kill): 115 µg/kg
|
N/R
|
TXAPA9 35,553,1976
|
subcutaneous | rat
lowest published toxic dose: 20 µg/kg
|
Liver: Changes in liver weight
|
TXAPA9 133,313,1995
|
subcutaneous | rat
lowest published toxic dose: 40 µg/kg
|
Liver: Changes in liver weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 133,313,1995
|
subcutaneous | rat
lowest published toxic dose: 2,500 ng/kg
|
Endocrine: Other changes
|
JDPHDH 15,337,1991
|
subcutaneous | rat
lowest published toxic dose: 2,500 ng/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
JDPHDH 15,337,1991
|
skin | human
lowest published toxic dose: 107 µg/kg
|
Skin: After topical application: Dermatitis, allergic
|
SCAMAC 254,29,1986
|
skin | monkey
lowest published toxic dose: 10 ng/kg
|
Blood: Other changes | Blood: Changes in leukocyte (WBC) count
TAEHC* VI:205,1,1998
|
skin | mouse
lowest published lethal dose: 80 µg/kg
|
Gastrointestinal: Other changes
|
RCOCB8 20,101,1978
|
skin | rabbit
lethal dose (50 percent kill): 275 µg/kg
|
N/R
|
EVHPAZ 5,87,1973
|
unreported route | human
lowest published toxic dose: 25 µg/kg
|
Gastrointestinal: Nausea or vomiting | Blood: Normocytic anemia Skin: After systemic exposure: Dermatitis, other
EVHPAZ 109,865,2001
|
unreported route | human
lowest published toxic dose: 6 µg/kg
|
Gastrointestinal: Nausea or vomiting | Skin: After systemic exposure: Dermatitis, other Biochemical: Metabolism (intermediary): Lipids including transport
EVHPAZ 109,865,2001
|
unreported route | mouse
lowest published lethal dose: 200 µg/kg
|
Liver: Fatty liver degeneration | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
ANYAA9 320,204,1979
|
unreported route | mouse
lowest published toxic dose: 0.32 µg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
TOXID9 72,109,2003
|
unreported route | mouse
lowest published toxic dose: 8 µg/kg
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
TOXID9 72,109,2003
|
unreported route | rat
lethal dose (50 percent kill): 0.25 mg/kg
|
N/R
|
TXAPA9 133,321,1995
|
unreported route | rat
lowest published lethal dose: 19 µg/kg
|
N/R
|
TXAPA9 187,128,2003
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 9,260 ng/kg/4 week- intermittent
|
Liver: Changes in liver weight | Endocrine: Changes in thymus weight Blood: Changes in erythrocyte (RBC) count
TOLED5 60,247,1992
|
intraperitoneal | mouse
lowest published toxic dose: 180 µg/kg/6 week- intermittent
|
Liver: Changes in liver weight | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
CMSHAF 14,949,1985
|
intraperitoneal | mouse
lowest published toxic dose: 120 µg/kg/12 week- intermittent
|
Liver: Changes in liver weight | Endocrine: Changes in thymus weight Blood: Changes in other cell count (unspecified)
CMSHAF 19,927,1989
|
intraperitoneal | rat
lowest published toxic dose: 240 ng/kg/8 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
TXCYAC 171,117,2002
|
oral | guinea pig
lowest published toxic dose: 441 ng/kg/90 day- continuous
|
Liver: Changes in liver weight | Endocrine: Changes in thymus weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
FAATDF 6,454,1986
|
oral | guinea pig
lowest published toxic dose: 1,600 ng/kg/8 week- intermittent
|
Endocrine: Changes in thymus weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
EVHPAZ 5,101,1973
|
oral | guinea pig
lowest published toxic dose: 5 µg/kg/5 week- intermittent
|
Endocrine: Other changes | Kidney, Ureter, and Bladder: Other changes Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
EVHPAZ 5,125,1973
|
oral | hamster
lowest published toxic dose: 600 µg/kg/3 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
BECTA6 31,649,1983
|
oral | mammal (species unspecified)
lowest published toxic dose: 1.68 µg/kg/14 day- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
VHTODE 43,22,2001
|
oral | mammal (species unspecified)
lowest published toxic dose: 3.36 µg/kg/28 day- continuous
|
Musculoskeletal: Changes in teeth and supporting structures | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
VHTODE 43,22,2001
|
oral | mammal (species unspecified)
lowest published toxic dose: 3.92 µg/kg/4 week- continuous
|
Behavioral: Somnolence (general depressed activity)
|
VHTODE 43,134,2001
|
oral | mammal (species unspecified)
lowest published toxic dose: 4.76 µg/kg/34 day- continuous
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
VHTODE 43,134,2001
|
oral | mammal (species unspecified)
lowest published toxic dose: 18.48 µg/kg/132 day- continuous
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Nutritional and Gross Metabolic: Weight loss or decreased weight gain
VHTODE 43,134,2001
|
oral | mammal (species unspecified)
lowest published toxic dose: 211.2 ng/kg/132 day- continuous
|
Blood: Other changes | Reproductive: Effects on fertility: Mating performance (e.g., # sperm positive females per # females mated; # copulations per # estrus cycles) Nutritional and Gross Metabolic: Changes in: Fe
VHTODE 43,134,2001
|
oral | monkey
lowest published toxic dose: 10 µg/kg/12 day- continuous
|
Gastrointestinal: Ulceration or bleeding from stomach | Nutritional and Gross Metabolic: Other changes Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
BECTA6 18,108,1977
|
oral | monkey
lowest published toxic dose: 2.143 µg/kg/120 day- intermittent
|
Immunological Including Allergic: Decreased immune response
|
TOSCF2 56,374,2000
|
oral | monkey
lowest published toxic dose: 170.4 µg/kg/240 day- intermittent
|
Reproductive: Other effects on female
|
TOSCF2 56,374,2000
|
oral | monkey
lowest published toxic dose: 5.35 µg/kg/30 week- continuous
|
Endocrine: Estrogenic | Endocrine: Other changes
ANYAA9 -,419,1979
|
oral | monkey
lowest published toxic dose: 0.535 µg/kg/30 week- continuous
|
Reproductive: Effects on fertility: Female fertility index (e.g., # females pregnant per # sperm positive females; # females pregnant per # females mated) | Reproductive: Maternal effects: Parturition
ANYAA9 -,419,1979
|
oral | mouse
lowest published toxic dose: 588 µg/kg/14 day- intermittent
|
Liver: Changes in liver weight | Endocrine: Changes in spleen weight Endocrine: Changes in thymus weight
TXAPA9 112,128,1992
|
oral | mouse
lowest published toxic dose: 20 µg/kg/4 week- intermittent
|
Endocrine: Other changes | Endocrine: Changes in thymus weight Immunological Including Allergic: Decrease in cellular immune response
EVHPAZ 5,149,1973
|
oral | mouse
lowest published toxic dose: 520 µg/kg/13 week- intermittent
|
Liver: Other changes | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTPTR* NTP-TR-209,1982
|
oral | mouse
lowest published toxic dose: 336 µg/kg/8 week- continuous
|
Blood: Other changes | Blood: Changes in leukocyte (WBC) count Immunological Including Allergic: Decrease in humoral immune response
JEPTDQ 4(2-3),401,1980
|
oral | mouse
lowest published toxic dose: 150 µg/kg/6 week- intermittent
|
Liver: Fatty liver degeneration | Endocrine: Changes in thymus weight Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
TXAPA9 29,229,1974
|
oral | mouse
lowest published toxic dose: 97.5 ng/kg/13 week- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) | Biochemical: Metabolism (intermediary): Plasma proteins not involving coagulation
TXAPA9 124,82,1994
|
oral | mouse
lowest published toxic dose: 12 µg/kg/4 day- intermittent
|
Liver: Changes in liver weight
|
TJADAB 33,29,1986
|
oral | mouse
lowest published toxic dose: 50 µg/kg/15 week- intermittent
|
Liver: Changes in liver weight | Tumorigenic: Increased incidence of tumors in susceptible strains Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
EVHPAZ 105,750,1997
|
oral | rat
lowest published toxic dose: 30 µg/kg/30 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Blood: Changes in platelet count Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
EVHPAZ 5,111,1973
|
oral | rat
lowest published toxic dose: 6,500 ng/kg/13 week- intermittent
|
Liver: Changes in liver weight | Endocrine: Changes in thymus weight Blood: Pigmented or nucleated red blood cells
TXAPA9 35,553,1976
|
oral | rat
lowest published toxic dose: 7,300 mg/kg/2 year- continuous
|
Liver: Hepatitis (hepatocellular necrosis), zonal | Liver: Changes in liver weight Kidney, Ureter, and Bladder: Other changes in urine composition
TXAPA9 46(2),279,1978
|
oral | rat
lowest published toxic dose: 16 µg/kg/16 week- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes in urine composition Biochemical: Metabolism (intermediary): Porphyrin including bile pigments
BCPCA6 31,1607,1982
|
oral | rat
lowest published toxic dose: 120 µg/kg/3 day- intermittent
|
Liver: Other changes | Nutritional and Gross Metabolic: Changes in: Fe Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
BECTA6 45,436,1990
|
oral | rat
lowest published toxic dose: 450 ng/kg/45 week- intermittent
|
Kidney, Ureter, and Bladder: Other changes in urine composition
|
TXAPA9 57,156,1981
|
oral | rat
lowest published toxic dose: 140 µg/kg/14 day- intermittent
|
Blood: Change in clotting factors | Blood: Changes in erythrocyte (RBC) count Blood: Changes in platelet count
EVHPAZ 5,119,1973
|
oral | rat
lowest published toxic dose: 3 µg/kg/80 day- continuous
|
Endocrine: Changes in thymus weight | Immunological Including Allergic: Decrease in humoral immune response
EJPHAZ 293,429,1995
|
oral | rat
lowest published toxic dose: 2.9 µg/kg/30 day- continuous
|
Endocrine: Changes in thymus weight | Immunological Including Allergic: Decrease in humoral immune response
EJPHAZ 293,429,1995
|
oral | rat
lowest published toxic dose: 70 µg/kg/13 week- intermittent
|
Endocrine: Changes in thymus weight | Nutritional and Gross Metabolic: Weight loss or decreased weight gain Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
CMSHAF 29,2381,1994
|
oral | rat
lowest published toxic dose: 41.9 µg/kg/13 week- intermittent
|
Blood: Changes in platelet count | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 146,217,1997
|
oral | rat
lowest published toxic dose: 7,000 ng/kg/28 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Lipids including transport
CMSHAF 43,807,2001
|
oral | rat
lowest published toxic dose: 28,000 ng/kg/28 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Liver: Changes in liver weight Blood: Microcytosis with or without anemia
CMSHAF 43,807,2001
|
oral | rat
lowest published toxic dose: 22.75 µg/kg/91 day- continuous
|
Liver: Changes in liver weight | Endocrine: Changes in thymus weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
CMSHAF 25,2023,1992
|
oral | rat
lowest published toxic dose: 2.275 µg/kg/91 day- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
CMSHAF 25,2023,1992
|
oral | rat
lowest published toxic dose: 10 µg/kg/7 day- intermittent
|
Skin and Appendages: Other: Breast | Related to Chronic Data: Changes in ovarian weight Related to Chronic Data: Changes in uterine weight
EVHPAZ 103,708,1995
|
oral | rat
lowest published toxic dose: 2.9 µg/kg/30 day- continuous
|
Endocrine: Changes in thymus weight | Immunological Including Allergic: Decrease in cellular immune response
EPEPEG 293,429,1995
|
oral | rat
lowest published toxic dose: 3 µg/kg/180 day- continuous
|
Immunological Including Allergic: Decrease in cellular immune response
|
EPEPEG 293,429,1995
|
oral | rat
lowest published toxic dose: 13 µg/kg/13 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Metabolism (intermediary): Other
BCPCA6 32,991,1983
|
oral | rat
lowest published toxic dose: 7 µg/kg/4 week- continuous
|
Endocrine: Evidence of thyroid hypofunction
|
CMSHAF 25,1239,1992
|
oral | rat
lowest published toxic dose: 0.7 µg/kg/4 week- continuous
|
Biochemical: Metabolism (intermediary): Other
|
CMSHAF 25,1239,1992
|
oral | rat
lowest published toxic dose: 2.275 µg/kg/13 week- continuous
|
Liver: Other changes | Nutritional and Gross Metabolic: Conditioned vitamin deficiency
CMSHAF 25,1239,1992
|
oral | rat
lowest published toxic dose: 105 µg/kg/5 week- continuous
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
VHTODE 43,22,2001
|
oral | rat
lowest published toxic dose: 45 ng/kg/45 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects | Related to Chronic Data: Changes in prostate weight Related to Chronic Data: Changes in testicular weight
JJATDK 22,345,2002
|
oral | rat
lowest published toxic dose: 72.8 µg/kg/2 year- intermittent
|
Cardiac: Cardiomyopathy including infarction | Vascular: Structural changes in vessels Liver: Other changes
TOXID9 72,30,2003
|
oral | rat
lowest published toxic dose: 900 ng/kg/90 day- intermittent
|
Brain and Coverings: Recordings from specific areas of CNS | Brain and Coverings: Other degenerative changes
TOXID9 72,77,2003
|
oral | rat
lowest published toxic dose: 45 ng/kg/45 day- intermittent
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes Related to Chronic Data: Changes in testicular weight
JAPTO* 22,345,2002
|
oral | rat
lowest published toxic dose: 45 ng/kg/45 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases | Related to Chronic Data: Changes in prostate weight
JAPTO* 22,345,2002
|
oral | rat
lowest published toxic dose: 450 ng/kg/30 week- intermittent
|
Brain and Coverings: Other degenerative changes
|
JJTHEC 65,825,2002
|
oral | rat
lowest published toxic dose: 3,300 ng/kg/30 week- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
JJTHEC 65,825,2002
|
oral | rat
lowest published toxic dose: 3,500 ng/kg/5 week- intermittent
|
Liver: Fatty liver degeneration | Liver: Changes in liver weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXAPA9 191,12,2003
|
oral | rat
lowest published toxic dose: 45 ng/kg/45 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects | Biochemical: Metabolism (intermediary): Lipids including transport Related to Chronic Data: Changes in testicular weight
TXCYAC 171,127,2002
|
oral | rat
lowest published toxic dose: 3,000 ng/kg/60 day- intermittent
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Related to Chronic Data: Changes in prostate weight Related to Chronic Data: Changes in testicular weight
TOXID9 72,362,2003
|
oral | rat
lowest published toxic dose: 0.7 µg/kg/28 day- intermittent
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Other proteins
TXCYAC 178,45,2002
|
oral | rat
lowest published toxic dose: 275 ng/kg/64 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Metabolism (intermediary): Other proteins
TOXID9 72,361,2003
|
oral | rabbit
lowest published toxic dose: 80 µg/kg/8 week- intermittent
|
Immunological Including Allergic: Decrease in cellular immune response | Immunological Including Allergic: Decrease in humoral immune response Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTIS** OTS0544117
|
subcutaneous | rat
lowest published toxic dose: 3,500 ng/kg/5 week- intermittent
|
Liver: Other changes | Liver: Changes in liver weight Tumorigenic: Cells (cultured) transformed
CRNGDP 15,1143,1994
|
subcutaneous | rat
lowest published toxic dose: 6,300 ng/kg/9 week- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
|
CRNGDP 15,1143,1994
|
subcutaneous | rat
lowest published toxic dose: 140 ng/kg/20 week- intermittent
|
Liver: Other changes
|
TOXID9 72,363,2003
|
subcutaneous | rat
lowest published toxic dose: 17 µg/kg/19 week- intermittent
|
Musculoskeletal: Changes in teeth and supporting structures
|
TOSCF2 69,482,2002
|
subcutaneous | rat
lowest published toxic dose: 170 µg/kg/19 week- intermittent
|
Vascular: Structural changes in vessels | Musculoskeletal: Changes in teeth and supporting structures
TOSCF2 69,482,2002
|
skin | mouse
lowest published toxic dose: 97 µg/kg/13 week- intermittent
|
Liver: Hepatitis (hepatocellular necrosis), diffuse | Blood: Changes in spleen Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NCITR* NCI-TR-201-82
|
skin | mouse
lowest published toxic dose: 8 mg/kg/20 week- intermittent
|
Liver: Changes in liver weight | Skin: After systemic exposure: Dermatitis, other Tumorigenic: Facilitates action of known carcinogens
TXAPA9 102,362,1990
|
skin | mouse
lowest published toxic dose: 200 µg/kg/20 week- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Liver: Changes in liver weight Liver: Fatty liver degeneration
FCTOD7 42,1217,2004
|
skin | mouse
lowest published toxic dose: 200 ng/kg/1 week- intermittent
|
Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
|
FCTOD7 42,1217,2004
|
skin | mouse
lowest published toxic dose: 300 ng/kg/3 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
FCTOD7 42,1217,2004
|
skin | mouse
lowest published toxic dose: 15 µg/kg/3 day- intermittent
|
Biochemical: Metabolism (intermediary): Lipids including transport
|
FCTOD7 42,1217,2004
|
unreported route | mouse
lowest published toxic dose: 5.5 µg/kg/14 day- intermittent
|
Reproductive: Maternal effects: Breasts, lactation (prior to or during pregnancy)
|
TOXID9 72,121,2003
|
unreported route | mouse
lowest published toxic dose: 15 µg/kg/14 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Reproductive: Maternal effects: Breasts, lactation (prior to or during pregnancy)
TOXID9 72,230,2003
|
unreported route | rat
lowest published toxic dose: 9,100 ng/kg/13 week- intermittent
|
Liver: Other changes
|
TOXID9 72,264,2003
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 69,33,1997
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Inadequate Evidence
|
IMEMDT 15,41,1977
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Sufficient Evidence
|
IMSUDL 7,350,1987
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Limited Evidence
|
IMEMDT 69,33,1997
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 1
|
IMEMDT 69,33,1997
|
TOXICOLOGY REVIEW
|
|
RREVAH 59,1,1975
|
TOXICOLOGY REVIEW
|
|
ARPAAQ 94,125,1972
|
TOXICOLOGY REVIEW
|
|
CHRYAQ 47(2),15,1974
|
TOXICOLOGY REVIEW
|
|
TXCYAC 3,187,1975
|
TOXICOLOGY REVIEW
|
|
RPZHAW 26,623,1975
|
TOXICOLOGY REVIEW
|
|
BIOGAL 40(2),44,1974
|
TOXICOLOGY REVIEW
|
|
STEVA8 2,305,1974
|
TOXICOLOGY REVIEW
|
|
EVHPAZ 15,121,1976
|
TOXICOLOGY REVIEW
|
|
FCTXAV 17,95,1979
|
TOXICOLOGY REVIEW
|
|
PHTHDT 7,513,1979
|
TOXICOLOGY REVIEW
|
|
MUREAV 47,141,1978
|
TOXICOLOGY REVIEW
|
|
ARTODN 40,161,1978
|
TOXICOLOGY REVIEW
|
|
EVSRBT 2,708,1973
|
TOXICOLOGY REVIEW
|
|
NTIS** PB82-922905
|
TOXICOLOGY REVIEW
|
|
MEPAAX 29,59,1978
|
TOXICOLOGY REVIEW
|
|
VHTODE 22,31,1980
|
TOXICOLOGY REVIEW
|
|
MGLFDB -,123,1978
|
TOXICOLOGY REVIEW
|
|
FCTOD7 25,257,1987
|
TOXICOLOGY REVIEW
|
|
ARPTDI 22,517,1982
|
TOXICOLOGY REVIEW
|
|
ARPTDI 43,309,2003
|
TOXICOLOGY REVIEW
|
|
TOLED5 134,3,2002
|
TOXICOLOGY REVIEW
|
|
TOLED5 138,9,2003
|
TOXICOLOGY REVIEW
|
|
TOLED5 140-141,3,2003
|
TOXICOLOGY REVIEW
|
|
MUREAV 5611472004
|
TOXICOLOGY REVIEW
|
|
ARTODN 44,211,1980
|
TOXICOLOGY REVIEW
|
|
DMTRAR 13,387,1982
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - AUSTRIA
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - FINLAND
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - FRANCE
|
Carcinogen, JAN1993
|
Occupational Exposure Limit - GERMANY
|
Carcinogen, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
Carcinogen, JAN1999
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO TCDD-air
|
Carcinogen lowest feasible concentration
|
NIOSH* DHHS #92-100,1992
|
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X7301; |
Number of Industries 1; Total Number of Facilities 3; Number of Occupations 1; Total Number of Employees Exposed 14; Total Number of Female Employees Exposed 5 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/89/214522/AS)
|
EPA GENETOX PROGRAM 1988, Positive: Carcinogenicity-mouse/rat
|
EPA GENETOX PROGRAM 1988, Negative: Rodent dominant lethal
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH CURRENT INTELLIGENCE BULLETIN 40, 1984
|
NCI Carcinogenesis Studies (gavage);clear evidence:mouse,rat
|
NCI Carcinogenesis Bioassay (dermal);clear evidence:mouse
|
NCITR* NCI-TR-201,1982
|
NTP 11th Report on Carcinogens,2004:Known to be human carcinogen
|
NTP Carcinogenesis studies; on test (two year studies), October 2000
|
NTP Carcinogenesis studies; on test (prechronic studies), October 2000
|
NTP Carcinogenesis studies; test completed (peer review), October 2000
|
|
REFERENCES:
CODEN
|
|
REFERENCE
AECTCV
|
Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973-
|
AMBOCX
|
Ambio. A Journal of the Human Environment. (Pergamon Press Inc., Maxwell House, Fairview
Park, Elmsford, NY 10523) V.1- 1972-
|
ANYAA9
|
Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New
York, NY 10021) V.1- 1877-
|
ARPAAQ
|
Archives of Pathology. (Chicago, IL) V.5(3)-50(3), 1928-50; V.70-99, 1960-75. For publisher
information, see APLMAS.
|
ARPTDI
|
Annual Review of Pharmacology and Toxicology. (Annual Reviews, Inc., POB 10139, Palo Alto, CA
94303) V.16- 1976-
|
ARTODN
|
Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep.
Ger.) V.32- 1974-
|
ATSUDG
|
Archives of Toxicology, Supplement. (Springer-Verlag New York, Inc., Service Center, 44 Hartz
Way, Secaucus, NJ 07094) No.1- 1978-
|
ATXKA8
|
Archiv fuer Toxikologie. (Berlin, Fed. Rep. Ger.) V.15-31, 1954-74. For publisher
information, see ARTODN.
|
BBRCA9
|
Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St.,
Duluth, MN 55802) V.1- 1959-
|
BCPCA6
|
Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1958-
|
BECTA6
|
Bulletin of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc.,
Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1966-
|
BESCE5
|
Biomedical and Environmental Sciences. (Academic Press, 525 B St., Suite 1900, San Diego, CA
92101) V.1- 1988-
|
BIOGAL
|
Biologico. (Instituto Biologica, Av. Cons. Rodriques Alves, 1252, CEP 04014, Sao Paulo,
Brazil) V.1- 1935-
|
BIREBV
|
Biology of Reproduction. (Soc. for the Study of Reproduction, 309 W. Clark St., Champaign, IL
61820) V.1- 1969-
|
BIRSB5
|
Biology of Reproduction, Supplement. (Champaign, IL) No.1-4, 1969-71(?). Discontinued. For
publisher information, see BIREBV.
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CBINA8
|
Chemico-Biological Interactions. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1969-
|
CHRYAQ
|
Chemistry. (Washington, DC) V.18-52, 1944-79.
|
CJPPA3
|
Canadian Journal of Physiology and Pharmacology. (National Research Council of Canada,
Publication Sales and Distribution, Ottawa ON K1A OR6, Canada) V.42- 1964-
|
CMSHAF
|
Chemosphere. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-
1972-
|
CRNGDP
|
Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford
OX8 1JJ, UK) V.1- 1980-
|
CRTOEC
|
Chemical Research in Toxicology. (American Chemical Soc., Distribution Office Dept. 223, POB
57/36, West End Station, Washington, DC 20037) V.1- 1988-
|
DCTODJ
|
Drug and Chemical Toxicology. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1-
1977/78-
|
DMTRAR
|
Drug Metabolism Reviews. (Marcel Dekker, 270 Madison Ave., New York, NY 10016) V.1- 1972-
|
EJPHAZ
|
European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1967-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENMUDM
|
Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see
EMMUEG.
|
ENVRAL
|
Environmental Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-
1967-
|
EPEPEG
|
European Journal of Pharmacology, Environmental Toxicology and Pharmacology Section. (Elsevier
Science Publishers B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.228- 1992-
|
ETOCDK
|
Environmental Toxicology and Chemistry. (Pergamon Press Inc., Maxwell House, Fairview Park,
Elmsford, NY 10523) V.1- 1982-
|
ETOPFR
|
Environmental Toxicology and Pharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA
19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1-
Feb.1996-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
EVSRBT
|
Environmental Science Research. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) V.1-
1972-
|
EXPEAM
|
Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FCTXAV
|
Food and Cosmetics Toxicology. (London, UK) V.1-19, 1963-81. For publisher information, see
FCTOD7.
|
FEPRA7
|
Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda,
MD) V.1-46, 1942-87.
|
HBPTO*
|
Handbook of pesticide toxicology. Robert Krieger ed, Academic press, 2001
|
IJIMDS
|
International Journal of Immunopharmacology. (Pergamon Press Inc., Maxwell House, Fairview
Park, Elmsford, NY 10523) V.1- 1979-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
IMSUDL
|
IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY
12210) No.1- 1979-
|
JAPTO*
|
Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex,
PO22 9SA England) V.1- 1981-
|
JBCHA3
|
Journal of Biological Chemistry. (428 E. Preston St., Baltimore, MD 21202) V.1- 1905-
|
JDPHDH
|
Journal of Developmental Physiology. (Oxford University Press, Pinkhill House, Southfield
Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1979-
|
JEPTDQ
|
Journal of Environmental Pathology and Toxicology. (Park Forest South, IL) V.1-5(3),
1977-81(?). For publisher information, see JEPOEC.
|
JJATDK
|
JAT, Journal of Applied Toxicology. (John Wiley & Sons Ltd., Baffins Lane, Chichester, W.
Sussex PO19 1UD, UK) V.1- 1981-
|
JJTHEC
|
Japanese Journal of Toxicology and Environmental Health. (Nippon Yakugakkai, 2-12-15 Shibuya,
Shibuya-ku, Tokyo 150, Japan) V.38- 1992-
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
LIFSAK
|
Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8,
1962-69; V.14- 1974-
|
LPDSAP
|
Lipids. (American Oil Chemists' Soc., POB 5037, Stn. A., Champaign, IL 61820) V.1- 1966-
|
MEPAAX
|
Medycyna Pracy. Industrial Medicine. (Ars-Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1-
1950-
|
MGLFDB
|
Monographs of the Giovanni Lorenzini Foundation. (New York, NY) V.1, 1978. Discontinued.
|
MOPMA3
|
Molecular Pharmacology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202)
V.1- 1965-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NATUAS
|
Nature. (Nature Subscription Dept., POB 1018, Manasguan, NJ 08736) V.1- 1869-
|
NCITR*
|
National Cancer Institute Carcinogenesis Technical Report Series. (Bethesda, MD) No.0-205.
For publisher information, see NTPTR*.
|
NETEEC
|
Neurotoxicology and Teratology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.9- 1987-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NRTXDN
|
Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979-
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
NTPTR*
|
National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709)
No.206-
|
PESTC*
|
Pesticide & Toxic Chemical News. (Food Chemical News, Inc., 400 Wyatt Bldg., 777 14th St.,
NW, Washington, DC 20005) V.1- 1972-
|
PHTHDT
|
Pharmacology and Therapeutics. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW,
UK) V.4- 1979-
|
PSSID2
|
Pergamon Series on Environmental Science. (Oxford, UK) V.1-7, 1978-82. Discontinued.
|
RCOCB8
|
Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966,
Westbury, NY 11590) V.1- 1970-
|
REPTED
|
Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1987-
|
RPZHAW
|
Roczniki Panstwowego Zakladu Higieny. (Ars Polona, POB 1001, 00-068 Warsaw 1, Poland) V.1-
1950-
|
RREVAH
|
Residue Reviews. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ
07094) V.1- 1962-
|
SCAMAC
|
Scientific American. (Scientific American, Inc., 415 Madison Ave., New York, NY 10017) V.1-
1859-
|
STEVA8
|
Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1972-
|
TAEHC*
|
Environmental Health Criteria (United Nations Environment Programme. Geneva, World Health
Organization) 1- 1976-
|
TCMUD8
|
Teratogenesis, Carcinogenesis, and Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New
York, NY 10003) V.1- 1980-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOSCF2
|
Toxicological Sciences (Oxford University Press, 6277 Sea Harbor Drive, Orlando, FL 32887 )
V. 41, Jan. 1998-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
VHTODE
|
Veterinary and Human Toxicology. (American College of Veterinary and Comparative Toxicology,
Publication Office, Comparative Toxicology, Manhattan, KS 66506) V.19- 1977-
|
|